These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17997024)

  • 1. Prognostic impact of comorbidity in patients with bladder cancer.
    Megwalu II; Vlahiotis A; Radwan M; Piccirillo JF; Kibel AS
    Eur Urol; 2008 Mar; 53(3):581-9. PubMed ID: 17997024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
    Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
    Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of age and comorbidity as prognostic indicators for patients with bladder cancer.
    Ha MS; Chang IH
    Asian J Androl; 2010 Sep; 12(5):766-74. PubMed ID: 20676116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort.
    Muilwijk T; Akand M; Soria F; Giordano A; Milenkovic U; Moris L; Gevaert T; Van Poppel H; Albersen M; Gontero P; Joniau S
    BJU Int; 2020 Dec; 126(6):704-714. PubMed ID: 32640103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.
    Goossens-Laan CA; Leliveld AM; Verhoeven RH; Kil PJ; de Bock GH; Hulshof MC; de Jong IJ; Coebergh JW
    Int J Cancer; 2014 Aug; 135(4):905-12. PubMed ID: 24420527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Froehner M; Muallah D; Koch R; Hübler M; Borkowetz A; Heberling U; Huber J; Wirth MP; Thomas C
    Urol Int; 2020; 104(1-2):62-69. PubMed ID: 31639810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
    Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
    Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
    Westergren DO; Gårdmark T; Lindhagen L; Chau A; Malmström PU
    J Urol; 2019 Nov; 202(5):905-912. PubMed ID: 31144594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
    Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
    Kim HS; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.
    Prout GR; Wesley MN; Yancik R; Ries LA; Havlik RJ; Edwards BK
    Cancer; 2005 Oct; 104(8):1638-47. PubMed ID: 16130136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.